Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis
Clinical trial NCT02344511 · WITHDRAWN
Trial details
- NCT number
- NCT02344511
- Sponsor
- Durata Therapeutics International BV (an Affiliate of Actavis, Inc.)
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2018-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.